2 results match your criteria: "Centre d'Expertise de la Mort Subite (CEMS)[Affiliation]"
Stent thrombosis after primary percutaneous coronary intervention in comatose survivors of out-of-hospital cardiac arrest: Are the new P2Y12 inhibitors really more effective than clopidogrel?
Resuscitation
January 2016
AP-HP Hôpital Cochin, Service de Cardiologie, Paris 75014, France; Université Paris Descartes, Faculté de Médecine, Paris 75014, France; INSERM U970, Centre d'Expertise de la Mort Subite (CEMS), Paris 75015, France. Electronic address:
Aim: High rates of stent thrombosis (ST) have been reported in patients with out-of-hospital cardiac arrest (OHCA) who require a primary percutaneous coronary intervention (PCI). The aim of this study was to assess risk factors of ST in this population with a special focus on antiplatelet therapy administered during the acute phase.
Materials And Methods: We conducted a retrospective observational study in patients treated with primary PCI after OHCA between 2011 and 2013 in our center.
Optimal antiplatelet therapy in out-hospital cardiac arrest patients treated by primary percutaneous coronary intervention.
Resuscitation
May 2015
AP-HP Hôpital Cochin, Service de Cardiologie, Paris 75014, France; Université Paris Descartes, Université Sorbonne Paris Cité, Paris 75014, France; INSERM U970, Centre d'Expertise de la Mort Subite (CEMS), Paris 75015, France. Electronic address: